CN102993270A - 甘氨酰-l-酪氨酸的制备工艺 - Google Patents
甘氨酰-l-酪氨酸的制备工艺 Download PDFInfo
- Publication number
- CN102993270A CN102993270A CN2011102728217A CN201110272821A CN102993270A CN 102993270 A CN102993270 A CN 102993270A CN 2011102728217 A CN2011102728217 A CN 2011102728217A CN 201110272821 A CN201110272821 A CN 201110272821A CN 102993270 A CN102993270 A CN 102993270A
- Authority
- CN
- China
- Prior art keywords
- tyrosine
- glycyl
- chloroacetyl
- reaction
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 title claims abstract description 60
- 108010087823 glycyltyrosine Proteins 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- GDOGSOZOUAVIFX-VIFPVBQESA-N (2s)-2-[(2-chloroacetyl)amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound ClCC(=O)N[C@H](C(=O)O)CC1=CC=C(O)C=C1 GDOGSOZOUAVIFX-VIFPVBQESA-N 0.000 claims abstract description 22
- 238000005915 ammonolysis reaction Methods 0.000 claims abstract description 21
- 239000012043 crude product Substances 0.000 claims abstract description 21
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000000047 product Substances 0.000 claims abstract description 12
- 238000007670 refining Methods 0.000 claims abstract description 6
- 238000006482 condensation reaction Methods 0.000 claims abstract description 5
- 238000001953 recrystallisation Methods 0.000 claims abstract description 5
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 28
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 18
- 239000008213 purified water Substances 0.000 claims description 16
- 229960004441 tyrosine Drugs 0.000 claims description 16
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 12
- 230000008025 crystallization Effects 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 claims 4
- 238000004090 dissolution Methods 0.000 claims 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 4
- 238000004440 column chromatography Methods 0.000 abstract description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 abstract description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 abstract description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 abstract description 2
- 239000001099 ammonium carbonate Substances 0.000 abstract description 2
- 235000019270 ammonium chloride Nutrition 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 43
- 238000001228 spectrum Methods 0.000 description 11
- 230000010354 integration Effects 0.000 description 8
- 239000007795 chemical reaction product Substances 0.000 description 4
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- -1 L -Tyrosine ester Chemical class 0.000 description 2
- CJUMAFVKTCBCJK-UHFFFAOYSA-N N-benzyloxycarbonylglycine Chemical compound OC(=O)CNC(=O)OCC1=CC=CC=C1 CJUMAFVKTCBCJK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- LDQAVQLJHUEMEY-JTQLQIEISA-N (2s)-2-(ethylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound CCN[C@H](C(O)=O)CC1=CC=C(O)C=C1 LDQAVQLJHUEMEY-JTQLQIEISA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- SBBWEQLNKVHYCX-JTQLQIEISA-N ethyl L-tyrosinate Chemical compound CCOC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SBBWEQLNKVHYCX-JTQLQIEISA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110272821.7A CN102993270B (zh) | 2011-09-15 | 2011-09-15 | 甘氨酰-l-酪氨酸的制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110272821.7A CN102993270B (zh) | 2011-09-15 | 2011-09-15 | 甘氨酰-l-酪氨酸的制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102993270A true CN102993270A (zh) | 2013-03-27 |
CN102993270B CN102993270B (zh) | 2015-04-08 |
Family
ID=47922434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110272821.7A Active CN102993270B (zh) | 2011-09-15 | 2011-09-15 | 甘氨酰-l-酪氨酸的制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102993270B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104447946A (zh) * | 2014-11-05 | 2015-03-25 | 济南康和医药科技有限公司 | 一种甘酪二肽一水合物的新晶型及其制备方法 |
CN105481945A (zh) * | 2016-01-04 | 2016-04-13 | 湖北泓肽生物科技有限公司 | 一种l-丙氨酰-l-酪氨酸的制备方法 |
CN106699839A (zh) * | 2015-08-17 | 2017-05-24 | 北京双鹭药业股份有限公司 | 化学法合成Diapin(甘-甘-亮,Gly-gly-leu)工艺 |
CN108101958A (zh) * | 2017-12-25 | 2018-06-01 | 湖北泓肽生物科技有限公司 | 一种甘氨酰-l-酪氨酸的精制方法 |
CN112552373A (zh) * | 2020-12-08 | 2021-03-26 | 河北一品制药股份有限公司 | 一种甘氨酰-l-酪氨酸的工业化制备方法 |
CN113880911A (zh) * | 2021-09-15 | 2022-01-04 | 湖北泓肽生物科技有限公司 | 一种甘氨酰-l-酪氨酸的合成方法 |
CN114605330A (zh) * | 2022-04-18 | 2022-06-10 | 济宁环聚医药科技有限公司 | 一种脱羧肌肽绿色制备工艺 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197998B1 (en) * | 1998-04-14 | 2001-03-06 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing N-glycyltyrosine and its crystal structure |
-
2011
- 2011-09-15 CN CN201110272821.7A patent/CN102993270B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197998B1 (en) * | 1998-04-14 | 2001-03-06 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing N-glycyltyrosine and its crystal structure |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104447946A (zh) * | 2014-11-05 | 2015-03-25 | 济南康和医药科技有限公司 | 一种甘酪二肽一水合物的新晶型及其制备方法 |
CN106699839A (zh) * | 2015-08-17 | 2017-05-24 | 北京双鹭药业股份有限公司 | 化学法合成Diapin(甘-甘-亮,Gly-gly-leu)工艺 |
CN106699839B (zh) * | 2015-08-17 | 2022-02-01 | 北京双鹭药业股份有限公司 | 化学法合成Diapin(甘-甘-亮,Gly-gly-leu)工艺 |
CN105481945A (zh) * | 2016-01-04 | 2016-04-13 | 湖北泓肽生物科技有限公司 | 一种l-丙氨酰-l-酪氨酸的制备方法 |
CN108101958A (zh) * | 2017-12-25 | 2018-06-01 | 湖北泓肽生物科技有限公司 | 一种甘氨酰-l-酪氨酸的精制方法 |
CN108101958B (zh) * | 2017-12-25 | 2020-06-02 | 湖北泓肽生物科技有限公司 | 一种甘氨酰-l-酪氨酸的精制方法 |
CN112552373A (zh) * | 2020-12-08 | 2021-03-26 | 河北一品制药股份有限公司 | 一种甘氨酰-l-酪氨酸的工业化制备方法 |
CN113880911A (zh) * | 2021-09-15 | 2022-01-04 | 湖北泓肽生物科技有限公司 | 一种甘氨酰-l-酪氨酸的合成方法 |
CN113880911B (zh) * | 2021-09-15 | 2023-11-14 | 湖北泓肽生物科技有限公司 | 一种甘氨酰-l-酪氨酸的合成方法 |
CN114605330A (zh) * | 2022-04-18 | 2022-06-10 | 济宁环聚医药科技有限公司 | 一种脱羧肌肽绿色制备工艺 |
CN114605330B (zh) * | 2022-04-18 | 2024-12-10 | 济宁环聚医药科技有限公司 | 一种脱羧肌肽绿色制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN102993270B (zh) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102993270B (zh) | 甘氨酰-l-酪氨酸的制备工艺 | |
CN110642897B (zh) | 一种β-烟酰胺核糖氯化物的制备方法 | |
CN105017082B (zh) | 一种心衰药Entresto 关键中间体(R)‑叔丁基 (1‑([1,1`‑联苯]‑4‑基)‑3‑羟基丙烷‑2‑基)氨基甲酸酯的制备方法 | |
WO2019097547A1 (en) | An improved process for the preparation of lifitegrast or salts thereof | |
CN102180823B (zh) | 一种精制脯氨酰胺的方法 | |
CN104447759B (zh) | 一种环二肽的生产方法 | |
CN102993271B (zh) | 甘氨酰-l-谷氨酰胺的制备方法 | |
US20160090352A1 (en) | Process for the purification of melphalan | |
CN108794520B (zh) | 包括埃沙佐米在内的硼酸柠檬酸酯类化合物的合成方法 | |
JP2008531642A (ja) | 薬学活性化合物イルベサルタンおよびその合成中間体を得る方法 | |
CN102127137A (zh) | 制备雌甾氨基酸酯的中间体化合物及其合成方法 | |
CN118546077A (zh) | 一种脂肪二酸片段的制备方法及应用 | |
CN115785110B (zh) | 吲哚啉并四氢吡喃类化合物、其制备方法及用途 | |
CN102924550A (zh) | 地西他滨5’-o-氨基酸酯类前药及其制备方法 | |
CN103965065B (zh) | 沙格列汀中间体、其盐、其制备方法及其用途 | |
CN109942514A (zh) | 一种制备硫酸阿扎拉韦中间体的方法 | |
CN102417474B (zh) | D-异谷氨酰基-d-色氨酸制备的新方法 | |
CN102363598B (zh) | 高纯度加巴喷丁的制备方法 | |
WO2009122433A2 (en) | A process for preparation of ramipril | |
RU2363695C2 (ru) | Способ получения периндоприла с использованием тетраметилурониевых солей в качестве реагентов реакции сочетания | |
EP2906536B1 (en) | An improved process for preparation of perindopril intermediate | |
CN113582902B (zh) | 布瓦西坦及其中间体的制备方法 | |
CN101580529A (zh) | 去羟肌苷前体药物及其制备方法 | |
CN102320908A (zh) | 一种β-氨基酸或其衍生物的制备方法 | |
JP2011121872A (ja) | 光学活性N−tert−ブトキシカルボニル−トランス−4−フルオロプロリンの精製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zheng Jiaqing Inventor after: Liu Mingming Inventor after: Liu Sujing Inventor after: Liu Jie Inventor after: Li Huayu Inventor after: Cui Liangfeng Inventor after: Liu Shugui Inventor after: Feng Bo Inventor after: Zhang Jianli Inventor after: Cui Meilan Inventor after: Li Jie Inventor after: Zhou Haiyang Inventor before: Zheng Jiaqing Inventor before: Liu Jie Inventor before: Niu Haigang Inventor before: Liu Shugui Inventor before: Feng Bo Inventor before: Zhang Jianli Inventor before: Cui Meilan Inventor before: Li Jie Inventor before: Zhou Haiyang Inventor before: Liu Mingming Inventor before: Liu Shujing |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHENG JIAQING LIU SHUGUI FENG BO ZHANG JIANLI CUI MEILAN LI JIE ZHOU HAIYANG LIU MINGMING LIU SHUJING LIU JIE NIU HAIGANG TO: ZHENG JIAQING LI HUAYU CUI LIANGFENG LIU SHUGUI FENG BO ZHANG JIANLI CUI MEILAN LI JIE ZHOU HAIYANG LIU MINGMING LIU SUJING LIU JIE |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20250218 Address after: No.17 Hongda Road, Linzi District, Zibo City, Shandong Province Patentee after: Shandong Qidu Biopharmaceutical Co.,Ltd. Country or region after: China Address before: Development Department of Shandong Qidu Pharmaceutical Co., Ltd., No. 28 Renmin East Road, Linzi District, Zibo City, Shandong Province 255400 Patentee before: SHANDONG QIDU PHARMACEUTICAL Co.,Ltd. Country or region before: China |